Courtesy: https://www.chittorgarh.com/
Review By Dilip Davda on June, 2026
• The company is currently engaged in fast moving e-HCV segment.
• It marked steady growth in its top and bottom lines for the reported periods.
• Considering its last traded price, the RI is at a discount of around 26%, making it a reasonable offer.
• The company is poised for bright prospects ahead in e-HCV segment.
• Well-informed investors may park funds for medium to long term.
ABOUT COMPANY:
Ravindra Energy Ltd., (REL) erstwhile known as Ravindra Trading & Agencies Ltd. – has a limited history in commercializing its offerings within a dynamic and rapidly evolving sustainable mobility business at its current scale, scope and complexity in an evolving market and economic environment, which makes it difficult to evaluate its current business, plans for future operations and strategic initiatives, predict future results, and evaluate future prospects, increasing the risk associated.
REL’s BaaS service model and battery-swapping infrastructure are capital-intensive and require significant upfront investment, and any inability to secure adequate funding on commercially acceptable terms or to achieve projected utilization and returns could materially and adversely affect its business, cash flows, financial condition, results of operations and prospects. Adoption of BaaS service model by corporates, fleet operators and transporters are very important for the success of its integrated platform for sustainable mobility, and any limited or slower-than-expected adoption could materially and adversely affect its business, financial condition, results of operations and prospects. Subscription arrangements may be subject to early termination or lower-than-expected utilization rates.
Its future growth is dependent upon market acceptance of e-HCVs as against the established market for diesel vehicles. The company relies on imports for key components and equipment. Any disruption in such imports or increase in their costs due to regulatory changes, economic conditions or trade tensions could materially and adversely affect its business, financial condition, results of operations and prospects. It faces risk and uncertainties when developing renewable energy projects which could cause delays to the completion of projects, increase its projects costs or result in the short closing of project capacity, thereby adversely affect cash flows, financial condition and prospects.
REL’s projects under the PM KUSUM scheme and state-level solarization programmes are dependent on the timely release of Central Financial Assistance (CFA) by MNRE and state subsidies/incentives, and any delay, reduction, or non-disbursement may adversely impact project viability, working capital requirements, cost structures and commissioning timelines. Its top 10 customers contributed 19.59%, 24.94% and 61.10% of Revenue from operations in Fiscals 2026, Fiscals 2025 and 2024, respectively. The offer document is silent on its employees’ strength data.
ISSUE DETAILS:
The company is coming out with its Rights Issue (RI) of 19832834 equity shares of Rs. 10 each at a fixed price of Rs. 101 per share to mobilize Rs. 200.31 cr. The RI opens for subscription on June 16, 2026, and will close on June 24, 2026. The company is offering RI in the ratio of 1 for 9 to its eligible stakeholders as of the record date of June 08, 2026. The company is asking for full money on application for number of shares applied. Post allotment, RI shares will be listed on BSE and NSE. The company is spending Rs. 1.60 cr. for this RI process, from the net proceeds, it will utilize Rs. 150.00 cr. for investment in EIM, and Rs. 48.71 cr. for general corporate purposes. Its provisions for GCP appears a bit dicey.
The RI is solely lead managed by the company itself., and KFin Technologies Ltd. is the registrar to the issue.
Post-RI, company’s current paid-up equity capital of Rs. 181.19 cr. will stand enhanced to Rs. 198.53 cr.Based on the RI pricing, the company is looking for a market cap of Rs. 2005.13 cr.
FINANCIAL PERFORMANCE:
On the financial performance front, for the last two fiscals, the company has (on a consolidated basis) posted total income / net profit, of Rs. 250.42 cr. / Rs. 21.81 cr. (FY25), Rs. 543.20 cr. / Rs 80.83 cr. (FY26). The company posted growth in its top and bottom lines for the reported periods. Its NAV stood at Rs. 24.62 as of March 31, 2026. Considering recent trends, the company is poised for bright prospects ahead with rising activities in e-HCV segment.
DIVIDEND POLICY:
The company has not paid any dividends for the reported periods of the offer document. It will adopt a prudent dividend policy, based on its financial performance and future prospects. The offer document is silent on its dividend policy.
SCRIP PERFORMANCE: BASED ON BSE WEBSITE DATA: SCRIP CODE: 504341 (FV Rs. 10).
The scrip last closed on cum-right basis at Rs. 127.85 on June 05, 2026, and opened on an ex-right basis at Rs. 125.20 on June 08, 2026. Since then, it has marked a high/low of Rs. 136.50 / Rs. 120.65. The scrip last closed at Rs. 136.10 as of June 12, 2026. For the last 52 weeks’ it has posted a high/low of Rs. 187.63 / Rs. 110.63. Based on the last traded price, the RI is at a discount of around 25.78%.
The promoters’ holding has declined to 63.66% for the quarter ended March 31, 2026, against 64.77% for previous two quarters ended on December 31, 2025. The counter is traded above the RI price.
Conclusion / Investment Strategy
REL is currently engaged in fast moving e-HCV segment. It marked steady growth in its top and bottom lines for the reported periods. Considering its last traded price, the RI is at a discount of around 26%, making it a reasonable offer. The company is poised for bright prospects ahead in e-HCV segment. Well-informed investors may park funds for medium to long term.
Review By Dilip Davda on June, 2026
Review Author
DISCLAIMER: No financial information whatsoever published anywhere here should be construed as an offer to buy or sell securities, or as advice to do so in any way whatsoever. All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions. My reviews do not cover GMP market and operators game plans. Readers must consult a qualified financial advisor before making any actual investment decisions, based the on information published here. With entry barriers, SEBI wants only well-informed investors to participate in such offers. With crazy listings in the recent past, SME IPOs drew the attention of investors across the board and lead to seer madness. However, as SME issues have entry barriers and continued low preference from the broking community, any reader taking decisions based on any information published here does so entirely at their own risk. The above information is based on information available as of date coupled with market perceptions. The Author has no plans to invest in this offer.
About Dilip Davda
Dilip Davda is veteran journalist associated with stock market since 1978. He is contributing to print and electronic media on stock markets/insurance/finance since 1985.
Dilip Davda is a leading reviewer of public issues and NCDs in the primary stock market in India. The knowledge he gained over 3 decades while working in the stock market and a strong relationship with popular lead managers makes his reviews unique. His detailed fundamental and financial analysis of companies coming up with IPOs helps investors in the primary stock market. Dilip Davda has a special interest in analyzing the SME companies and writing reviews about their public issues. His reviews are regularly published online and in news papers.
(Dilip Davda -SEBI registered Research Analyst-Mumbai,
Registration no. INH000003127 (Perpetual)
Email id: dilip_davda@rediffmail.com ).
Courtesy: https://www.chittorgarh.com/
